Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DNA study sheds light on myxoma resistance
Australia released myxomatosis in 1950 to tackle the burgeoning rabbit population.
Modern rabbits compared with specimens from before 1950s outbreak

An unprecedented rabbit DNA study has shed light on how rabbits have acquired resistance to myxomatosis.

Research led by the University of Cambridge and the CIBIO Institute in Porto looked at DNA from nearly 200 rabbits spanning 150 years and thousands of miles.

The team sequenced nearly 20,000 genes to pinpoint mutations since the myxomatosis pandemic in the 1950s.

According to findings published in the journal Science, modern rabbits in the UK, France and Australia, have acquired resistance to the myxoma virus through the same genetic changes. They also discovered that this process relied on lots of small mutations in different genes, rather than big changes in single genes.

Findings also suggest the protein that helps rabbits fight myxoma, also has an antiviral effect on an unrelated virus, vesicular stomatitis.

Miguel Carneiro, from CIBIO said: “While battling myxoma, rabbits may have increased their resistance to other viruses including, perhaps, rabbit haemorrhagic disease which is killing so many animals right now.”

Australia released myxomatosis in 1950 to tackle the burgeoning rabbit population, which was impacting the country’s native plants and animals. It is thought that the European rabbit was introduced to the country in the 1850s and within a century the population grew to hundreds of millions.

Within three months of releasing myxomatosis, it had spread 2,000km and killed 99 per cent of infected animals. It was illegally introduced to France in 1952 and spread to the UK in 1953, with similarly devastating consequences in all three countries.

Myxoma continues to present a serious threat to rabbits. Lead author Dr Joel Alves said: “Viral evolution appears to be finding ways to counter the genetic adaptations which we’ve observed. Recent, more virulent recent strains of myxoma virus, have been found to be extremely immunosuppressive. So the arms race goes on.”

As rabbit populations collapse across the UK and mainland Europe, researchers said the findings could provide clues to the future of the species.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.